definiens: shall mean the following intellectual property rights in any country within the Territory with claims that are limited to at least one CD22 - Based Compound(s ) ( including such CD22 - Based Compound(s ) in combination with an Antibody(ies ) which bind an antigen(s ) other than CD22 ), and/or a specific process for making at least one CD22 - Based Compound(s ) and/or a specific process of using at least one CD22 - Based Compound(s ) ( including such CD22 - Based Compound(s ) used in combination with an Antibody(ies ) which bind an antigen(s ) other than CD22 ) and that are owned or controlled by Irrimunomedics, in whole or in part : ( a ) any and all patent applications ( including all divisionals, continuations or continuations - in - part ) filed or having legal fcirce ; ( b ) any and all patents that have issued or in the future issue from the foregoing patent applications, including utility, model and design patents and certificates of invention ; and ( c ) any and all extensions or restorations by existing or future extension or restoration mechanisms, including without limitation, supplementary protection certificates or the equivalent thereof, substitutions, confirmations, reregistrations, reexaminations, revalidations, reissues, renewals, extensions or additions to any such foregoing patent applications and patents . For the avoidance of doubt this definition shall exclude intellectual property rights which claim radiolabeled versions of Antibodies which bind to CD22